Andersen Eric's Form 4 filing
Merrimack Pharmaceuticals Inc (MACK) · filed Nov 14, 2023
- Accession no.
- 0000950170-23-063800
- Filed
- Nov 14, 2023, 4:48 PM ET
- Trade date
- Nov 10-13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $661.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andersen EricCIK 0001517667 | Director, Other: See remarks |
| Western Standard Partners LPCIK 0001450414 | Other: See Remarks |
| Western Standard LLCCIK 0001517666 | Other: See Remarks |
| Western Standard Partners QP, L.P.CIK 0001544857 | Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2023 | Common Stock | PPurchaseAcquired | +29,803 | $12.32 | +$367,238.53 | 1,607,507 | Indirect | |
| Nov 10, 2023 | Common Stock | PPurchaseAcquired | +8,259 | $12.32 | +$101,769.05 | 445,461 | Indirect | |
| Nov 13, 2023 | Common Stock | PPurchaseAcquired | +12,191 | $12.39 | +$151,017.23 | 1,619,698 | Indirect | |
| Nov 13, 2023 | Common Stock | PPurchaseAcquired | +3,379 | $12.39 | +$41,857.7 | 448,840 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.